An In Vivo C. elegans Model System for Screening EGFR-Inhibiting Anti-Cancer Drugs

• Young-Ki Bae,

  Affiliation Comparative Biomedicine Research Branch, National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea

  ⨯
• Jee Young Sung,

  Affiliation Pediatric Oncology Research Branch, National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea

  ⨯
• Yong-Nyun Kim,

  Affiliation Comparative Biomedicine Research Branch, National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea

  ⨯
• Sunshin Kim,

  Affiliation New Experimental Therapeutics Branch, National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea

  ⨯
• Kyeong Man Hong,

  Affiliation Cancer Cell and Molecular Biology Branch, National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea

  ⨯
• Heung Tae Kim,

  Affiliation Center for Lung Cancer, National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea

  ⨯
• Min Sung Choi,

  Affiliation Department of Biological Sciences, Sungkyunkwan University, Suwon, Gyeonggi-do, Korea

  ⨯
• Jae Young Kwon,

  Affiliation Department of Biological Sciences, Sungkyunkwan University, Suwon, Gyeonggi-do, Korea

  ⨯
• Jaegal Shim

  * E-mail: jaegal@ncc.re.kr

  Affiliation Comparative Biomedicine Research Branch, National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea

  ⨯